Celiac disease is a common, familial autoimmune disease caused by exposure to gliadin in wheat, and related prolamins in barley and rye. The prevalence of the disease is approximately 1:133. Celiac disease can cause significant morbidity. The only treatment is a gluten-free diet. A genome-wide search of 405 microsatellite markers was performed on samples from 18 Bedouin families with a minimum of two cases of celiac disease. Non-parametric and parametric (including both dominant and recessive models of inheritance) linkage analyses were performed. The most significant genome-wide linkage evidence was at chromosome 3p26 with an HLod of 3.21, under the dominant model. The only other HLod or NPL greater than 2 was at 4q35, with an HLod of 2.15 under a dominant model. The region at 3p26, previously reported in two linkage analyses, harbors interleukin receptor genes, plausible candidates for celiac disease.
Introduction
Celiac disease (CD, MIM212750) is a familial, autoimmune disease caused by sensitivity to dietary wheat gliadins as well as related prolamins in rye and barley. CD is a common disease, with a disease frequency of 1:133 in the US; 1, 2 it is one of the most significant causes of chronic malabsorption in children, with symptoms including diarrhea, abdominal pain and growth failure. Symptoms in adulthood include anemia, fatigue, weight loss, diarrhea, constipation, infertility and neurologic symptoms, although occult disease is frequently present with minimal symptoms. 3 Families with multiple cases of CD are common, and estimates for the risk to siblings have ranged from less than 5% to greater than 20%, with most estimates between 10 and 12%. [4] [5] [6] [7] CD has a strong genetic association with the human leukocyte antigen (HLA) class II genes DQA1 and DQB1, with approximately 90% of celiacs carrying the DQ2 genotype (DQA1*05 and DQB1*02 alleles) and 5% carrying the DQ8 genotype (DQA1*03 and DQB1*0302 alleles). 8 However, the HLA association alone is insufficient to explain the hereditary nature of the disease, and is estimated to explain less than half the sibling risk, [9] [10] [11] [12] indicating the presence of one or more additional susceptibility loci.
There have been multiple genome-wide linkage studies to identify loci for CD (reviewed in van Heel et al., 13 Garner et al., 14 Eller et al.
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) and one genome-wide association study. 16 All studies have identified significant linkage evidence to the HLA region, except for one study of a large Bedouin family. However, there have been few significant linkages outside the HLA region and little to no confirmation of suggestive linkages. For complex diseases, difficulty in finding significant evidence for linkage and non-replication of linkage results are common, and may be due to a high degree of genetic heterogeneity among families and/or to the low power of studies to detect genes of relatively small effect. Altmuller et al. 17 reviewed 101 genome-wide linkage studies for complex diseases, and found that the only factors independently associated with study success were a large sample size and the study of one ethnic group (compared with multiple ethnic groups). Genetic isolation and inbreeding significantly reduce genetic heterogeneity, which can greatly facilitate linkage mapping. [18] [19] [20] [21] [22] [23] [24] Studies of Bedouins, a homogeneous inbred population from the Negev Desert in Israel, have identified genes for several disorders, including nonsyndromic recessive deafness, 25 Bardet-Biedl syndrome, 26, 27 catecholamine-induced ventricular tachycardia, 28 congenital dyserythropoietic anemia type I, 29, 30 and glycogenosis type VI (Hers disease). 31 In this study, we report the results from a genomewide linkage analysis of 18 Bedouin pedigrees with from 2 to 8 CD cases per family and a total of 72 cases of CD.
Results and discussion
Multipoint linkage analysis was performed on nine extended and nine nuclear pedigrees. The type of family, number of individuals genotyped and the number of CD A genome-wide screen for celiac disease YC Ding et al cases within each family are shown in Table 1 . Probands were CD patients with a reported family history of CD from the Pediatric Gastroenterology Clinic of the Soroka University Medical Center, Israel, the only hospital in the Negev region. Families were ascertained through sequential sampling of first-degree relatives of CD cases, with diagnostic criteria as described in Garner et al. 14 The results of the multipoint linkage analysis are shown in Figure 1 Multipoint linkage results for autosomal chromosomes. Genotypes from a 10-cM density microsatellite marker genome scan of 405 short-tandem repeat (STR) markers were analyzed. The program SimWalk2 (version 2.91) 41 was used for analysis, as the pedigrees had a high level of consanguinity, making the use of standard likelihood-based linkage analysis impossible. For the model-free analysis, the NPL_ALL A genome-wide screen for celiac disease YC Ding et al A genome-wide screen for celiac disease YC Ding et al
It is possible that the unaffected sibling carrying the haplotype will still develop the disease. Linkage on chromosome 4q with a HLod of 2.15 (a ¼ 0.55) was found under the dominant inheritance model, with the linkage peak at D4S408, mapping to chromosome 4q35. The 1ÀLod unit confidence interval exceeded 40 cM. An NPL of 1.63 was observed at the linkage peak, maximizing in the same location as the HLod. The HLod under the recessive model just exceeded 0.50 in the same region.
Linkage at 3p26 (6-26 cM from end of p-arm) was previously described in a genome-wide linkage analysis of 60 North American CD families (HLod ¼ 3.2 at D3S3050; 14.5 cM from the end of the p-arm) 32 and in a genome-wide linkage analysis of Scandinavian affected sib-pairs (NPL ¼ 1.74, P ¼ 0.040). 33 Although none of these studies by themselves meet strict criteria for genome-wide significance, the linkage is compelling, given that it is now reported in both Caucasians and Bedouins. A joint analysis of the North American Caucasian and Bedouin families is planned. Three candidate genes in this region include interleukin 5 (IL-5) receptor a, IL-17 receptor E and IL-17 receptor C. Increased expression of IL-5, T helper 2 cytokine has been detected in the intestinal mucosa of patients with CD as compared with controls. 34, 35 For the IL-17 family of receptors, numerous immune regulatory functions have been reported, with accumulating data supporting a role of IL-17 in certain organ-specific autoimmune disease. 36 A locus on chromosome 5q31-33, encompassing IL-5, IL-13, IL-4, IL-9 and IL-17B, had been identified as being linked to CD in Italian cohorts and replicated by three other studies, 13 and a genome-wide association study found association at 4q27, where IL-21 and IL-2 are located, 16 suggesting, in combination with our results, that interleukins and their receptors may play roles in the causation of CD.
It is accepted that HLA-DQ2 (DQa1*0501, DQb1*0201) and to a lesser extent, HLA-DQ8, are necessary for most CD. This DQ2 genotype is found in greater than 90% of CD cases of Northern European descent and in approximately 12-26% of controls. [37] [38] [39] As expected, most genome-wide linkage studies have reported highly significant evidence of linkage in the HLA region (at 30-50 cM). We previously had genotyped the DQA1 and DQB1 loci in nine of the families and found that the HLA-DQ2 and DQ8 high-risk genotypes associated with CD were similar to that observed in individuals of European ancestry. 40 However, in this analysis, we saw no evidence for linkage to HLA across the 18 pedigrees. Eller et al. 15 performed a genome-wide linkage analysis of one large Bedouin pedigree with CD and also did not find evidence of linkage to the HLA region. They hypothesized that the high frequency of the CDassociated haplotypes resulted in an inability to determine alleles that are identical by descent versus by state, reducing the power to detect linkage.
In conclusion, we identified two regions with evidence for linkage to CD in Bedouin population. The first region is 3p26, a region reported independently in previously linkage analyses, which harbors three plausible candidate genes: IL-5 receptor-a, IL-17 receptor E and IL-17 receptor C. The second region is 4q35, with no obvious candidate gene being identified.
